Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
OwnerR. Hollenbeckinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerR. Hollenbeckinventor
Estimating the term…
The present invention relates to liquid sustained release suspension dosage forms comprising ionized forms of water-soluble drugs. In particular, the invention encompasses a liquid form controlled release drug composition comprising a dispersed phase comprising an ion-exchange matrix drug complex comprising a pharmaceutically acceptable ion-exchange matrix and a water-soluble electrolytic drug associated with the ion-exchange matrix, wherein the surface charge of the ion-exchange matrix is opposite that of the electrolytic drug wherein the dispersed phase further comprises a non-electrolytic, soluble component having low molecular weight and a diffusion controlling membrane and a dispersion medium substantially free of diffusible counterions, further comprising an excipient capable of associating with water and impeding water activity such that drug dissolution is inhibited prior to administration. The invention also provides methods for preparing such compositions and methods of treatment.
A liquid form controlled release drug composition, comprising:
A liquid form controlled release drug composition, comprising:
The composition of claim 19, wherein the ion-exchange matrix is alginic acid.
A liquid form controlled release drug composition, comprising hydrophilic beads coated with a diffusion controlling membrane comprising albuterol, alginic acid, and lactose, wherein the beads are suspended in a dispersion medium that is 65% sucrose on a weight by weight basis.
A method for preparing a liquid form controlled release drug composition, comprising:
Dependencies are inferred from the claim text.